Literature DB >> 9314458

Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis.

E E Telzak1, B A Fazal, C L Pollard, G S Turett, J E Justman, S Blum.   

Abstract

For hospitalized patients with smear-positive pulmonary or laryngeal tuberculosis, the Centers for Disease Control and Prevention recommends that three consecutive sputum samples be negative for acid-fast bacilli (AFB) before respiratory isolation is discontinued. Limited data are available to predict the length of time to obtain three negative sputum smears and cultures and to determine factors associated with a prolonged interval before sputum smear and culture conversion, especially among patients infected with human immunodeficiency virus (HIV). For 100 consecutive patients with smear-positive pulmonary tuberculosis, the mean and median numbers of days from the initiation of appropriate therapy to the first of three consecutive negative smears were calculated, and associated risk factors were determined. The mean number of days before the first of three consecutive negative sputum smears was 33 days; the median was 23 days. On stepwise multiple regression analysis, cavitary disease, numerous AFB on the initial smear, and no prior history of tuberculosis were the factors independently associated with an increased number of days for both smear and culture conversion. HIV does not prolong the period of infectiousness.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314458     DOI: 10.1086/513772

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

Review 1.  Drug-resistant tuberculosis: what do we do now?

Authors:  A Telenti; M Iseman
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

2.  Aerosolized gentamicin reduces the burden of tuberculosis in a murine model.

Authors:  Chad J Roy; Satheesh K Sivasubramani; Noton K Dutta; Smriti Mehra; Nadia A Golden; Stephanie Killeen; James D Talton; Badre E Hammoud; Peter J Didier; Deepak Kaushal
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

3.  Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka.

Authors:  W Jayakody; A D Harries; S Malhotra; S de Alwis; S Samaraweera; N Pallewatta
Journal:  Public Health Action       Date:  2013-03-21

4.  Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.

Authors:  Vivian Kawai; Giselle Soto; Robert H Gilman; Christian T Bautista; Luz Caviedes; Luz Huaroto; Eduardo Ticona; Jaime Ortiz; Marco Tovar; Victor Chavez; Richard Rodriguez; A Roderick Escombe; Carlton A Evans
Journal:  Am J Trop Med Hyg       Date:  2006-12       Impact factor: 2.345

Review 5.  Inhaled drug delivery for tuberculosis therapy.

Authors:  Pavan Muttil; Chenchen Wang; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

6.  Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.

Authors:  Sean P Fitzwater; Luz Caviedes; Robert H Gilman; Jorge Coronel; Doris LaChira; Cayo Salazar; Juan Carlos Saravia; Krishna Reddy; Jon S Friedland; David A J Moore
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

Review 7.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  How soon should patients with smear-positive tuberculosis be released from inpatient isolation?

Authors:  David J Horne; Catherine O Johnson; Eyal Oren; Christopher Spitters; Masahiro Narita
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

9.  Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia.

Authors:  Trevino A Pakasi; Elvina Karyadi; Ni Made Desy Suratih; Michael Salean; Nining Darmawidjaja; Hans Bor; Koos van der Velden; Wil M V Dolmans; Jos W M van der Meer
Journal:  Nutr J       Date:  2010-09-28       Impact factor: 3.271

10.  Smear microscopy and culture conversion rates among smear positive pulmonary tuberculosis patients by HIV status in Dar es Salaam, Tanzania.

Authors:  Mbazi Senkoro; Sayoki G Mfinanga; Odd Mørkve
Journal:  BMC Infect Dis       Date:  2010-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.